L&K Biomed Ltd. (KOSDAQ:156100)
South Korea · Delayed Price · Currency is KRW 9,070.00
-280.00 (-2.99%)
At close: Mar 19, 2026
L&K Biomed Market Cap
L&K Biomed has a market cap or net worth of 203.4 billion as of March 20, 2026. Its market cap has increased by 41.89% in one year.
Market Cap
203.40B
Enterprise Value
209.41B
Revenue
38.92B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,070.00
Market Cap Chart
Since November 30, 2016, L&K Biomed's market cap has increased from 114.44B to 203.40B, an increase of 77.73%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 203.40B | -25.38% |
| Dec 30, 2025 | 272.58B | 106.21% |
| Dec 30, 2024 | 132.18B | -34.87% |
| Dec 28, 2023 | 202.96B | 89.01% |
| Dec 29, 2022 | 107.38B | -25.42% |
| Dec 30, 2021 | 143.97B | -71.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Next Biomedical | 650.57B |
| ASTERASYS Co.,Ltd | 437.23B |
| MEDIANA Co.,Ltd | 366.26B |
| SELVAS Healthcare | 114.44B |
| Remed | 101.53B |
| Neofect | 100.94B |
| Noul Co.,Ltd. | 84.37B |
| Hironic | 74.74B |